evidence based, best in class

TOTAL COMPLICATION RATE

COMPLETION OF THERAPY

MAX GRAVITY FLOW

THROMBOSIS/OCCLUSION

POWER INJECTION

INFECTION RATE PER 1,000 CATHETER DAYS

POWERWAND demonstrates less fibrin and thrombus formation in comparison to BIOFLO™ catheter (in-vivo)

POWERWAND CATHETER

3 minutes
45x magnification

30 minutes
45x magnification

3 minutes
Scanning Electron microscope

BIOFLO CATHETER

3 MINUTES
45X MAGNIFICATION

30 MINUTES
45X MAGNIFICATION

3 MINUTES
SCANNING ELECTRON MICROSCOPE

Catheter contamination/CLABSI risk:

During the most common procedure (seldinger technique) of CVC insertion, the catheter comes into direct contact with the skin as it enters into the vessel. These catheters have a 16.7% rate (5 in 30 patients) of bacterial surface contamination which increases the risk of a CLABSI.

Air Embolism:

The CVC WAND offers the only air competent, peelable introducer sheath in the market. Since October 2008, CMC has deemed Intravascular Air Embolism a non-reimbursable event (a NEVER EVENT). The mortality rate from air embolism ranges from 23-50%.